Therapeutic Effects of Intrabone and Systemic Mesenchymal Stem Cell Cytotherapy on Myeloma Bone Disease and Tumor GrowthXIN LI; WEN LING; SHARMIN KHAN et al.Journal of bone and mineral research (Print). 2012, Vol 27, Num 8, pp 1635-1648, issn 0884-0431, 14 p.Article

Role of decorin in the antimyeloma effects of osteoblastsXIN LI; PENNISI, Angela; YACCOBY, Shmuel et al.Blood. 2008, Vol 112, Num 1, pp 159-168, issn 0006-4971, 10 p.Article

Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth. CommentaryEDWARDS, Claire M; QIANG, Ya-Wei; SHAUGHNESSY, John D et al.Blood. 2008, Vol 112, Num 2, issn 0006-4971, 216-217, 374-382 [11 p.]Article

Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivoYACCOBY, Shmuel; WEN LING; FENGHUANG ZHAN et al.Blood. 2007, Vol 109, Num 5, pp 2106-2111, issn 0006-4971, 6 p.Article

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activityYACCOBY, Shmuel; PEARSE, Roger N; JOHNSON, Cherie L et al.British journal of haematology. 2002, Vol 116, Num 2, pp 278-290, issn 0007-1048Article

Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survivalYUN GE; FENGHUANG ZHAN; BARLOGIE, Bart et al.British journal of haematology. 2006, Vol 133, Num 1, pp 83-92, issn 0007-1048, 10 p.Article

Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell linesXIN LI; PENNISI, Angela; FENGHUANG ZHAN et al.British journal of haematology. 2007, Vol 138, Num 6, pp 802-811, issn 0007-1048, 10 p.Article

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone diseasePENNISI, Angela; XIN LI; WEN LING et al.British journal of haematology. 2009, Vol 145, Num 6, pp 775-787, issn 0007-1048, 13 p.Article

Seven-year median time to progression with thalidomide for smoldering myeloma : partial response identifies subset requiring earlier salvage therapy for symptomatic diseaseBARLOGIE, Bart; VAN RHEE, Frits; ANAISSIE, Elias et al.Blood. 2008, Vol 112, Num 8, pp 3122-3125, issn 0006-4971, 4 p.Article

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo. CommentaryDRAKE, Matthew T; RAJKUMAR, S. Vincent; PENNISI, Angela et al.American journal of hematology. 2009, Vol 84, Num 1, issn 0361-8609, 1-2, 6-14 [11 p.]Article

Cancer and the microenvironment : Myeloma-osteoclast interactions as a modelYACCOBY, Shmuel; WEZEMAN, Michele J; HENDERSON, Aminah et al.Cancer research (Baltimore). 2004, Vol 64, Num 6, pp 2016-2023, issn 0008-5472, 8 p.Article

Soluble syndecan-1 promotes growth of myeloma tumors in vivoYANG YANG; YACCOBY, Shmuel; WEI LIU et al.Blood. 2002, Vol 100, Num 2, pp 610-617, issn 0006-4971Article

Antimyeloma efficacy of thalidomide in the SCID-hu modelYACCOBY, Shmuel; JOHNSON, Cherie L; MAHAFFEY, Susan C et al.Blood. 2002, Vol 100, Num 12, pp 4162-4168, issn 0006-4971, 7 p.Article

Heparanase promotes the spontaneous metastasis of myeloma cells to boneYANG YANG; MACLEOD, Veronica; KELLY, Thomas et al.Blood. 2005, Vol 105, Num 3, pp 1303-1309, issn 0006-4971, 7 p.Article

Highly activated and expanded natural killer cells for multiple myeloma immunotherapyGARG, Tarun K; SZMANIA, Susann M; SUVA, Larry J et al.Haematologica (Roma). 2012, Vol 97, Num 9, pp 1348-1356, issn 0390-6078, 9 p.Article

Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patientsZANGARI, Maurizio; ESSELTINE, Dixie; CAVALLO, Federica et al.American journal of hematology. 2007, Vol 82, Num 9, pp 831-833, issn 0361-8609, 3 p.Article

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patientsZANGARI, Maurizio; YACCOBY, Shmuel; ESSELTINE, Dixie et al.Haematologica (Roma). 2011, Vol 96, Num 2, pp 333-336, issn 0390-6078, 4 p.Article

Identification of early growth response protein 1 (EGR-1 ) as a novel target for JUN-induced apoptosis in multiple myelomaLIJUAN CHEN; SIQING WANG; FENGHUANG ZHAN et al.Blood. 2010, Vol 115, Num 1, pp 61-70, issn 0006-4971, 10 p.Article

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsCOLLA, Simona; FENGHUANG ZHAN; WEI XIONG et al.Blood. 2007, Vol 109, Num 10, pp 4470-4477, issn 0006-4971, 8 p.Article

Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse modelYACCOBY, Shmuel; WEZEMAN, Michele J; EPSTEIN, Joshua et al.Haematologica (Roma). 2006, Vol 91, Num 2, pp 192-199, issn 0390-6078, 8 p.Article

The molecular classification of multiple myelomaFENGHUANG ZHAN; YONGSHENG HUANG; ANAISSIE, Elias et al.Blood. 2006, Vol 108, Num 6, pp 2020-2028, issn 0006-4971, 9 p.Article